Business / Finance

RSS

Adeptus Health closes $175 million of new senior secured credit facilities

Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., today announced that it has closed on $175 million of new senior secured credit facilities. Bank of America Merrill Lynch served as administrative agent. Bank of Montreal and SunTrust Bank served as co-syndication agents.

7 Oct 2015

VWR announces acquisition of Purification Technologies

VWR, a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Purification Technologies Inc., a specialty solvent company that performs high volume purification of selected high purity solvents. This acquisition will enhance VWR's growing laboratory and production chemical manufacturing portfolio to better support its laboratory and biopharmaceutical manufacturing customers.

7 Oct 2015

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Lonza Houston, Inc., a global leader in biological, cell and viral gene therapy manufacturing, and Benitec Biopharma, a clinical stage biotechnology company commercializing a patented gene-silencing technology, DNA-directed RNA interference (ddRNAi), today announced that they have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process for Benitec's ddRNAi-based, Adeno-Associated Virus (AAV)-delivered products intended for therapeutic use in humans.

7 Oct 2015

Agfa HealthCare awarded new three-year DR contract with Premier, Inc.

Agfa HealthCare announced today that it has been awarded a new three-year group purchasing contract with Premier, Inc., a leading healthcare improvement company, to provide its entire product line of digital radiography (DR) solutions to the alliance's approximately 3,600 member hospitals and 120,000 other alternate healthcare sites in the United States.

From Agfa HealthCare 7 Oct 2015

New UV-Vis spectrophotometer simplifies sample quality decisions

Life scientists who work with DNA, RNA and proteins can make educated decisions about sample suitability in experiments using a standalone, microvolume spectrophotometer for accurate quantitation and purity measurements to ensure downstream application success.

From Thermo Fisher Scientific Inc. 6 Oct 2015

Michigan researchers use Raman spectroscopy to study various childhood diseases

Renishaw, a world leader in metrology and spectroscopy, reports on the use of its inVia confocal Raman microscope in the study of various diseases–with a major focus on childhood diseases–at the Children's Hospital of Michigan and Wayne State University.

6 Oct 2015

FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept

Sandoz, a Novartis company and the global leader in biosimilars, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen’s US-licensed Enbrel (etanercept) - a tumor necrosis factor alpha (TNF-α) inhibitor

5 Oct 2015

Aspen Park Pharmaceuticals acquires worldwide rights to APP-111 therapy from Ohio State University

Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).

30 Sep 2015

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Generex Biotechnology Corporation today announced that it has entered into a non-binding Letter of Intent (LOI) with Hema Diagnostic Systems, LLC (HDS), a Florida company that designs and manufactures proprietary infectious disease detection technologies.

30 Sep 2015

Tunitas Therapeutics completes $10 million Series A venture financing

Tunitas Therapeutics, Inc. today announced the close of a $10 million Series A venture financing. The financing was co-led by Ally Bridge Group and WuXi Ventures, with the further participation of RA Capital Advisors.

30 Sep 2015

AMO Pharma raises $25 million in private equity financing

AMO Pharma Limited, a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, announced today that the company has raised $25 million in private equity financing from Woodford Investment Management.

30 Sep 2015

Craneware to host Financial Performance Summit in Las Vegas from October 20 to 22, 2015

Craneware, Inc., the healthcare market leader in automated value cycle solutions, will host the Financial Performance Summit on October 20 - 22, 2015 in Las Vegas.

29 Sep 2015

Philips showcases latest patient-driven sleep and respiratory solutions at the European Respiratory Society International Congress 2015

Philips Respironics, a business of Royal Philips, will showcase its latest portfolio of sleep-disordered breathing and respiratory solutions September 26-29 at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians can experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.

From Philips Healthcare 28 Sep 2015

Merck KGaA, Darmstadt, Germany makes progress toward closing planned acquisition of Sigma-Aldrich

Sigma-Aldrich Corporation announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany. The closing is now expected within the next two months.

28 Sep 2015

Lima to acquire Zimmer Unicompartmental High Flex Knee and Discovery Elbow System for Japanese market

Lima Corporate announces it has entered into an agreement with Zimmer Biomet Holdings, Inc. for the acquisition of the Zimmer Unicompartmental High Flex Knee and the Discovery Elbow System for the Japanese market.

28 Sep 2015

TSX approves Aeterna Zentaris' Series B Warrant amendment

Aeterna Zentaris Inc. announced today that The Toronto Stock Exchange has approved its previously announced amendment to its outstanding Series B Common Share Purchase Warrants agreed to with the holders of approximately 90% of the holders of the Series B Warrants intended to reduce the dilutive effect of the exercise of the Series B Warrants by establishing a cap on the number of shares issuable upon alternate net cashless exercise of the Series B Warrants until the close of business on November 17, 2015 and by limiting the number of shares that the Consenting Holders may sell until the close of business on October 9, 2015.

26 Sep 2015

Genovate begins construction of Insulin Ecological Industrial Park in Changzhou National Hi-tech District

On September 22, construction of phase I of Genovate Biotechnology's Insulin Ecological Industrial Park began in Changzhou National Hi-tech District. Changzhou mayor Fei Gaoyun said the city and district governments and the relevant oversight authorities will do their best to provide support services, with the aim of doing what is needed to see construction completed and the facility put into production as early as possible.

26 Sep 2015

Apax-advised funds sign definitive agreement to acquire interest in Ideal Protein

Funds advised by Apax Partners LLP, a global private equity firm, today announced that they have entered into a definitive agreement to acquire an interest in Ideal Protein, a proprietary weight loss and wellness solutions company. Terms of the transaction were not disclosed.

26 Sep 2015

Cryoport purchases IP rights to Cryoportal operating platform from Klatu

Cryoport, Inc. today announced the purchase of certain intellectual property and intellectual property rights to the Cryoportal operating platform from KLATU Networks, LLC.

24 Sep 2015

Florida Institute finalizes funding agreement with Aviana

The Florida Institute for the Commercialization of Public Research announced today that it has finalized a funding agreement with Aviana Molecular Technologies, an Orlando-based company with technology developed at the University of Central Florida.

24 Sep 2015

Business / Finance

Adeptus Health closes $175 million of new senior secured credit facilities

VWR announces acquisition of Purification Technologies

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Agfa HealthCare awarded new three-year DR contract with Premier, Inc.

New UV-Vis spectrophotometer simplifies sample quality decisions

Michigan researchers use Raman spectroscopy to study various childhood diseases

FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept

Aspen Park Pharmaceuticals acquires worldwide rights to APP-111 therapy from Ohio State University

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Tunitas Therapeutics completes $10 million Series A venture financing

AMO Pharma raises $25 million in private equity financing

Craneware to host Financial Performance Summit in Las Vegas from October 20 to 22, 2015

Philips showcases latest patient-driven sleep and respiratory solutions at the European Respiratory Society International Congress 2015

Merck KGaA, Darmstadt, Germany makes progress toward closing planned acquisition of Sigma-Aldrich

Lima to acquire Zimmer Unicompartmental High Flex Knee and Discovery Elbow System for Japanese market

TSX approves Aeterna Zentaris' Series B Warrant amendment

Genovate begins construction of Insulin Ecological Industrial Park in Changzhou National Hi-tech District

Apax-advised funds sign definitive agreement to acquire interest in Ideal Protein

Cryoport purchases IP rights to Cryoportal operating platform from Klatu

Florida Institute finalizes funding agreement with Aviana

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Latest News